Endocrine and Diabetes Biomarkers

A biomarker is defined as any substance, structure, or process that can be measured in the body or its products and influence or predict the incidence of outcome or disease. For the purpose of predicting type 1 diabetes, a biomarker should be present in a subset of the population, and this subset should have a bias in the proportion of people in whom type 1 diabetes develops. A biomarker should also present a quantifiable risk for the development of type 1 diabetes within a defined period or diagnose a “stage” in the progression to clinical or symptomatic type 1 diabetes. As described in this article, most of the biomarkers used for the prediction of type 1 diabetes are islet-specific supporting the concept that, before overt hyperglycemia, type 1 diabetes is predominantly a targeted disease rather than a systemic disease.

Atomic Biomarkers can be separated as "a trademark that is precisely measured and gaged as a pointer of typical natural methods, pathogenic methodology, or pharmacologic reactions to a pharmaceutical intercession.

Biomarkers have fundamental influence in driving clinical trials and treating patients. Progresses in sub-atomic diagnostics help medicinal experts make proficient, experimentally legitimate choices. All the more efficient disclosure and use of biomarkers in the development of ant diabetes medications will rely on upon quickening our comprehension of the pathogenesis of diabetes and particularly its macro vascular entanglements. Procedural upgrades from different fields, particularly tumor, are starting to demonstrate the way towards better models of diabetes pathogenesis and atomic biomarker revelation.

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular marker for metabolic syndrome
  • Molecular Marker-Hypoglycemic response
  • Inflammatory markers: Type 2 diabetes
  • Pharmacotherapy in treatment of diabetes

 

    Related Conference of Endocrine and Diabetes Biomarkers

    October 30-31, 2020

    Annual Summit on Metabolomics

    Vancouver, Canada
    November 09-10, 2020

    International Congress and Expo on Diabetic Care

    Bangkok, Thailand
    November 13-14, 2020

    International Conference on Diabetes and Heart Diseases

    Bangkok, Thailand
    November 16-17, 2020

    World Congress and Expo on Diabetes

    Kyoto, Japan
    November 16-17, 2020

    2nd Asia Pacific Diabetes and Endocrinology Congress

    Brisbane, Australia
    November 18-19, 2020

    Annual congress on Diabetes and Endocrinology Congress

    Bangkok, Thailand
    December 07-08, 2020

    13th World Congress on Endocrinology and Metabolic Disorders

    Auckland, Newzealand
    February 08-09, 2021

    Global summit on Diabetes and Endocrinology

    London, UK
    March 17-18, 2021

    30th European Diabetes Congress

    Barcelona, Spain
    May 10-11, 2021

    30th World Diabetes & Heart Congress

    Singapore, Singapore
    September 02-03, 2021

    5th Annual Congress on Diabetes, Obesity and Its Complications

    Vienna, Australia
    October 18-19, 2021

    2nd Annual Summit on Diabetes and Endocrinology

    Paris, France

    Endocrine and Diabetes Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in